Search results
If at First Tirzepatide Doesn't Succeed, Keep Trying
Medscape· 22 hours agoWhen using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off. New post hoc data from Lilly's SURMOUNT-1 trial of people with...
Targeting Obesity to Improve HFpEF Outcomes
Medscape· 22 hours agoButler: I am absolutely delighted to have this discussion with Dr Kosiborod on the issues pertaining to obesity and heart failure because, for one thing,...
Obesity linked to 32 cancer types as disease 'fuels 40% of cases', experts warn
The US Sun· 7 hours agoGETTING fat could be a factor in four out of 10 cancers, a major study has found. Experts say ...
Study finds poor muscle health is common in people living with obesity, increases risk of early...
Medical Xpress· 5 hours agoNew research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12–15 May)...
Do sex differences in how adipose tissue responds to insulin explain why type 2 diabetes is more...
Medical Xpress· 5 hours agoNew research presented at the European Congress on Obesity (ECO) in Venice, Italy (12–15 May), and...
Kids and Anti-Obesity Meds: Real-World Challenges
Medscape· 22 hours agoThe ability to provide adolescents with highly effective anti-obesity medications that now carry approvals from the US Food and Drug Administration (FDA)...
How we can bridge the obesity-care gap for Black Americans
theGrio via AOL· 1 day agoOPINION: It is time to advocate for legislative changes that will ensure every individual has access...
Nearly half of all cancer cases are linked to obesity
Daily Telegraph· 7 hours agoThe study led by Lund University in Malmo, Sweden, involved 4.1 million participants who were...
1 in 8 adults has taken Ozempic or other GLP-1 drug: Survey
The Hill· 9 hours agoA poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1...
Does Medicare Cover Wegovy?
Verywell Health via Yahoo News· 11 hours agoDespite the broader availability of Wegovy, Medicare’s coverage for anti-obesity medications remains limited...
